Survival of Mycobacterium bovis BCG oral vaccine during transit through a dynamic in vitro model simulating the upper gastrointestinal tract of badgers
Open Access
- 19 April 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (4) , e0214859
Abstract
In developing an oral bait BCG vaccine against tuberculosis in badgers we wanted to understand the conditions of the gastrointestinal tract and their impact on vaccine viability. Conditions mimicking stomach and small-intestine caused substantial reduction in BCG viability. We performed in vivo experiments using a telemetric pH monitoring system and used the data to parameterise a dynamic in vitro system (TIM-1) of the stomach and small intestine. Some BCG died in the stomach compartment and through the duodenum and jejunum compartments. BCG survival in the stomach was greatest when bait was absent but by the time BCG reached the jejunum, BCG viability was not significantly affected by the presence of bait. Our data suggest that from a starting quantity of 2.85 ± 0.45 x 108 colony-forming units of BCG around 2 log10 may be killed before delivery to the intestinal lymphoid tissue. There are economic arguments for reducing the dose of BCG to vaccinate badgers orally. Our findings imply this could be achieved if we can protect BCG from the harsh environment of the stomach and duodenum. TIM-1 is a valuable, non-animal model with which to evaluate and optimise formulations to maximise BCG survival in the gastrointestinal tract.Keywords
Funding Information
- Department for Environment, Food and Rural Affairs (SE3246)
This publication has 39 references indexed in Scilit:
- Sustained protection against tuberculosis conferred to a wildlife host by single dose oral vaccinationVaccine, 2013
- BCG Vaccination Reduces Risk of Tuberculosis Infection in Vaccinated Badgers and Unvaccinated Badger CubsPLOS ONE, 2012
- Protection of Eurasian badgers (Meles meles) from tuberculosis after intra-muscular vaccination with different doses of BCGVaccine, 2011
- Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgersProceedings Of The Royal Society B-Biological Sciences, 2010
- Survival and metabolic activity of the GanedenBC30 strain of Bacillus coagulans in a dynamic in vitro model of the stomach and small intestineBeneficial Microbes, 2010
- Fed and fasted gastric pH and gastric residence time in conscious beagle dogsJournal of Pharmaceutical Sciences, 2009
- Oral Vaccination of Guinea Pigs with aMycobacterium bovisBacillus Calmette-Guérin Vaccine in a Lipid Matrix Protects against Aerosol Infection with VirulentM. bovisInfection and Immunity, 2008
- Improving protective efficacy of BCG vaccination for wildlife against bovine tuberculosisResearch in Veterinary Science, 2005
- Effects of intravenous ketamine on gastrointestinal motility in the dogIntensive Care Medicine, 1995
- Absorption of Mycobacterium bovis BCG administered by the oral routeVaccine, 1987